Suppr超能文献

潘塞提(Ponseti)马蹄足管理时机:年龄是否重要?90 例儿童(131 足),平均随访 5 年。

Timing for Ponseti clubfoot management: does the age matter? 90 children (131 feet) with a mean follow-up of 5 years.

机构信息

a Department of Orthopaedics , Zhujiang Hospital of Southern Medical University , Guangzhou ;

b Ying-Hua Medical Group of Bone and Joint Healthcare in Children , Shanghai ;

出版信息

Acta Orthop. 2018 Dec;89(6):662-667. doi: 10.1080/17453674.2018.1526534. Epub 2018 Oct 18.

Abstract

Background and purpose - There are still controversies as to the age for beginning treatment with the Ponseti method. We evaluated the clinical outcome with different age at onset of Ponseti management for clubfoot. Patients and methods - 90 included children were divided into 3 groups in terms of age at start of treatment. The difference in treatment-related and prognosis-related variables including presentation age, initial Pirani and Dimeglio score, casts required, relapse rates, final Dimeglio score, and international clubfoot study group score (ICFSG) was analyzed. Results - Age between 28 days and 3 months at start of treatment method was associated with fewer casts required, lower relapse rate, and lower final ICFSG score (p < 0.05). Early treatment before 28 days of age required more casts and had a higher relapse rate (p < 0.05). The highest ICFSG scores were found in the ages between 3 and 6 months (p < 0.05). After propensity score matching, age between 28 days and 3 months was demonstrated to have a lower finial ICFSG score. Linear regression models showed that presentation age was positively correlated with final ICFSG score, and was identified as the only independent prognostic risk factor. Interpretation - There was lower rate of relapse and better clinical outcome when treatment was initiated at age between 28 days and 3 months. With the Ponseti method, clubfeet may not need urgent treatment.

摘要

背景与目的

对于开始采用潘塞提(Ponseti)方法治疗的年龄,仍存在争议。我们评估了不同起始治疗年龄的潘塞提治疗马蹄内翻足的临床结果。

患者与方法

90 例患儿根据治疗起始年龄分为 3 组。分析了与治疗相关和预后相关的变量的差异,包括发病年龄、初始皮拉尼(Pirani)和迪梅格利奥(Dimeglio)评分、所需石膏数量、复发率、最终迪梅格利奥评分和国际马蹄内翻足研究组评分(ICFSG)。

结果

治疗方法起始时年龄在 28 天至 3 个月之间与所需石膏数量较少、复发率较低和最终 ICFSG 评分较低相关(p < 0.05)。28 天以内开始治疗需要更多的石膏,复发率更高(p < 0.05)。3 至 6 个月之间的 ICFSG 评分最高(p < 0.05)。经过倾向评分匹配后,28 天至 3 个月之间的年龄显示出较低的最终 ICFSG 评分。线性回归模型显示,发病年龄与最终 ICFSG 评分呈正相关,且被确定为唯一的独立预后危险因素。

解释

在 28 天至 3 个月之间开始治疗时,复发率较低,临床结果较好。对于采用潘塞提方法,马蹄内翻足可能不需要紧急治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86b/6300741/78abf41b3ed4/IORT_A_1526534_F0001_C.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验